tiprankstipranks
Kissei Pharmaceutical Co Ltd (JP:4547)
:4547
Japanese Market
Want to see JP:4547 full AI Analyst Report?

Kissei Pharmaceutical Co (4547) Income Statement

0 Followers

Kissei Pharmaceutical Co Income Statement

Last quarter (Q1 2026), Kissei Pharmaceutical Co's total revenue was ¥22.19B, an increase of 4.85% from the same quarter last year. In Q1, Kissei Pharmaceutical Co's net income was ¥4.52B. See Kissei Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 26Mar 25Mar 24Mar 23
Total Revenue
¥ 88.33B¥ 97.41B¥ 75.58B¥ 67.49B¥ 65.38B
Gross Profit
¥ 44.06B¥ 45.82B¥ 37.34B¥ 32.38B¥ 31.24B
Operating Expenses
¥ 38.29B¥ 48.74B¥ 33.32B¥ 33.50B¥ 32.64B
Depreciation and Amortization
¥ 4.62B¥ 4.64B¥ 4.25B¥ 4.11B¥ 3.73B
EBITDA
¥ 20.25B¥ 1.72B¥ 18.72B¥ 17.81B¥ 20.26B
Operating Income
¥ 5.77B¥ -2.93B¥ 4.02B¥ -1.13B¥ -1.40B
Other Income/Expenses
¥ 9.84B¥ 19.82B¥ 10.43B¥ 14.81B¥ 17.91B
Pretax Income
¥ 15.61B¥ 16.89B¥ 14.45B¥ 13.68B¥ 16.51B
Net Income
¥ 11.96B¥ 13.78B¥ 11.16B¥ 10.53B¥ 12.92B
Per Share Metrics
Basic EPS
¥ 274.20¥ 331.53¥ 246.58¥ 228.30¥ 280.19
Diluted EPS
¥ 274.20¥ 331.53¥ 246.58¥ 228.30¥ 280.19
Weighted Average Shares Outstanding
43.62M 41.56M 45.26M 46.12M 46.12M
Weighted Average Shares Outstanding (Diluted)
43.62M 41.56M 45.26M 46.12M 46.12M
Currency in JPY

Kissei Pharmaceutical Co Earnings and Revenue History